Earnings Preview: Hologic
Medical device manufacturer Holgoic (NASDAQ: HOLX) is set to release its quarterly earnings results on Monday after the closing bell. Heading into the report, Wall Street analysts have consensus earnings per share estimates for the company of $0.37. This represents earnings growth of 8.82 percent versus the year ago period. The high estimate on Wall Street is $0.39 per share with a low estimate of $0.34.
Sales are expected to be $581.62 million which represents year over year growth of 24.50 percent versus the $467.04 million that Hologic reported in last year's corresponding quarter. The high revenue estimate is $590.91 million with a low estimate of $562.09 million.
Over the last 3 months, earnings estimates for the company have risen by one penny from $0.36 to $0.37. During this time period, HOLX has added around 2 percent. On Friday, ahead of Monday's key report, HOLX climbed 1.25 percent to close at $20.32. The 52-week high in the stock is $22.16 and this level could come into play if the company surprises estimates to the upside on Monday.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.